期刊文献+

P-ERK、P-p38及iNOS、GLUT4在冠心病患者冬眠心肌中表达及意义 被引量:2

Significances of P-ERK,P-p38,iNOS and GLUT4 expressions in hibernating myocardium of patients with cardiac arterial disease
下载PDF
导出
摘要 目的探讨冬眠心肌(HM)细胞内磷酸化ERK(P-ERK)、磷酸化p38(P-p38)、葡萄糖转运因子4(GLUT4)、诱导型一氧化氮合酶(iNOS)的变化和意义,探讨P-ERK、P-p38与GLUT4、iNOS的关系。方法选择行冠脉搭桥手术的冠心病患者10例,术前1周用多巴酚丁胺超声负荷试验结合多普勒组织成像确定HM及正常心肌(NM)的存在部位,术中根据检测结果取材,用免疫印迹法检测P-ERK、P-p38、iNOS、GLUT4的表达情况,分析HM与NM的P-ERK、P-p38、iNOS、GLUT4含量;分析四者之间的相关性。结果HM细胞内P-ERK、P-p38、GLUT4、iN-OS水平较正常心肌高;P-ERK与GLUT4呈正相关(r=0.665,P<0.05),P-p38与GLUT4、iNOS呈正相关(r=0.708、0.676,P<0.05)。结论心肌缺血缺氧可触发ERK、p38活化,活化的ERK、p38促使心肌细胞增加GLUT4及iNOS表达,促进HM形成。 Objective To observe changes of P-ERK, P-p38, inducible nitric oxide synthase (iNOS) and glucose transport type 4 (GLUT4) in hibernating myocardium(HM) and to explore the relationship of P-ERK, P-p38, iNOS and GLUT4. Methods Ten patients with stable ischemic ventricular dysfunction scheduled for bypass surgery underwent preoperative dobutamine stress echocardiography (DSE), doppler tissue image (DTI) to check the position of HM and intrao- perative myocardial biopsies. The normal myocardium(NH) and the HM were obtained in operation. They were confirmed by electron microscope. P-ERK,P-p38 ,iNOS and GLUT4 were detected by western-blot. The relationship of P-ERK,P-p38 and iNOS,GLUT4 were also analyzed. Results P-ERK, P-p38 , GLUT4 and iNOS were significantly increased in HM compared with normal myocardium. There were positive correlation between P-ERK and GLUT4, between P-p38 and GLUT4, between P-p38 and iNOS. Conclusion ERK and p38 could be triggered by ischemia ,and actived ERK and p38 could promote the expression of GLUT4 and iNOS, promote the formation of HM.
出处 《山东医药》 CAS 北大核心 2008年第42期10-12,共3页 Shandong Medical Journal
基金 江苏省卫生厅科技项目课题(H200329)
关键词 冬眠心肌 有丝分裂素激活蛋白激酶类 基因 p38 单糖转运蛋白质类 一氧化氮合酶 hibernating myocardium mitogen-activated protein kinases gene, p38 monosaccharide transport proteins nitric-oxide synthase
  • 相关文献

参考文献6

  • 1Edward O, Hou MX, Robert J. Activation of p38 MAPK and increased glucose transport in chronic hibernating swine myocardium [J]. Am J Physiol Heart Circ Physiol, 2004, 287 (3): 1328-1334.
  • 2Lasley RD,Keith BJ,Kristo G,et alDelayed adenosine Al receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent[J].Am J Physiol Heart Circ Physiol.2005.289(2):785-791.
  • 3Force T, Bonvetre JV. Growlh factors and mitogen-activated protein kinases[J]. Hylrerlension, 1998, 31(2):152-161.
  • 4lwai-Kanai E, Hasegawa K, Sawamura T, et al. Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis incultured neonatal rat cardiac myocytes[ J]. Circulation, 2001, 104(24) : 2948-2954.
  • 5Guo Y, Jones WK, Xuan YT, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of inducible NO synthase geng[J]. Proc Natl Acad Sci USA, 1999, 96(20) : 11507- 11512.
  • 6Bhat NR, Zhang P, Bhat AN. Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: role of p38 mitogen activated protein kinase activation [ J ]. J Neuroehem, 1999, 72 (2) : 472-478.

同被引文献33

  • 1蔡庆勇,梁贵友,牛义民,高振宇,宋宣统.体外循环心肌胰岛素抵抗的实验研究[J].遵义医学院学报,2006,29(4):347-350. 被引量:15
  • 2Augustin R. The protein family of glucose transport facilitators: It's not only about glucose after all[J]. IUBMB Life, 2010, 62(5) : 315-333.
  • 3Manolescu AR, Witkowska K, Kinnaird A, et al. Facilitated hexose transporters: new perspectives on form and function [J]. Physiology(Bethesda), 2007, 22(4): 234-240.
  • 4Schwenk RW, Luiken JJ, Bonen A, et al. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease[J]. Cardiovasc Res, 2008, 79(2): 249-258.
  • 5Macheda ML, Kelly DJ, Best JD, et al. Expression during rat fetal development of GLUT12-a member of the class Ⅲ hexose transporter family[J]. Anat Embryol ( Berl), 2002, 205(5-6): 441-452.
  • 6Huggins CE, Domenighetti AA, Ritchie ME, et al. Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper responsiveness to substrate intervention [J]. J Mol Cell Cardiol, 2008, 44(2) :270-280.
  • 7Kaczmarczyk SJ, Andrikopoulos S, Favaloro J, et al. Threshold effects of glucose transporter 4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy[J]. J Mol Endocrinol, 2003, 31(3): 449-459.
  • 8Ritchie RH, Quinn JM, Cao AH, et al. The antioxidant tempol inhibits cardiac hypertrophy in the insulin resistant GLUT4 deficient mouse in vivo[J]. J Mol Cell Cardiol, 2007, 42(6): 1119-1128.
  • 9Espinoza-Derout J, Wagner M, Salciccioli L, et al. Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein 1[J]. Circ Res, 2009, 104(12): 1347-1354.
  • 10Bateman RM, Tokunaga C, Kareco T, et al. Myocardial hypoxia-inducible HIF-la, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM 1 heterogeneity during endotoxemia[J]. Am J Physiol Heart Circ Physiol, 2007, 293(1): H448-H456.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部